Erlotinib Imp.14 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
2-((4-Chloro-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethyl formate in an impurity of Erlotinib (E625008) a EGFR-targeted drug in the treatment of non-small cell lung cancer.
Erlotinib Imp.14 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte